PL
PLX
Protalix BioTherapeutics, Inc.
$1.96
-1.51%
$157.9M
No data for this timeframe.
Vol
Market Cap$157.9M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (80%)
Inst. Holders7 funds
Inst. Value$3.9M
Inst. Activity4 buys / 0 sells
Reddit Sentiment50° Neutral
Exchange NYSE·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001006281·Prev Close $1.99
Recent Activity
Inst.
MORGAN STANLEY — ADD
131,987 shares ($237.6K)
Inst.
WELLS FARGO & COMPANY/MN — ADD
79,002 shares ($142.2K)
May 13, 2026
earnings_calendar
PLX Q1 2026 Earnings Scheduled — 2026-05-13
Price Targets
$11.00
+455.6% upside
Strong Buy
Current $1.98
Low $10.00
Median $11.00
High $12.00
2 analysts
$10.00
$12.00
Analyst Ratings
1Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 19, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.01 ▼ -103.7% | $-0.03 — $0.01 | 0% YoY | 2 |
| Next Q | $-0.01 | $-0.03 — $0.01 | -133% YoY | 2 |
| Current FY | $0.20 ▼ -9.3% | $0.14 — $0.25 | 344% YoY | 2 |
| Next FY | $0.05 ▼ -28.6% | $-0.02 — $0.12 | -74% YoY | 2 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $2.3M | ADD |
| VANGUARD GROUP INC | $879.4K | NEW |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $315.1K | NEW |
| MORGAN STANLEY | $237.6K | ADD |
| WELLS FARGO & COMPANY/MN | $142.2K | ADD |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
7 institutional holders with $3.9M total value (2,186,578 shares) as of 2025-Q4. Top holders: RENAISSANCE, VANGUARD, CHARLES. Net buying activity: 4 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 1,263,300 | $2.3M | 57.8% | ADD +35.8% |
| 2 | VANGUARD GROUP INC | 488,552 | $879.4K | 22.3% | NEW |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 175,070 | $315.1K | 8.0% | NEW |
| 4 | MORGAN STANLEY | 131,987 | $237.6K | 6.0% | ADD +85.8% |
| 5 | WELLS FARGO & COMPANY/MN | 79,002 | $142.2K | 3.6% | ADD +84.5% |
| 6 | BANK OF AMERICA CORP /DE/ | 46,352 | $83.4K | 2.1% | DOUBLED +130.4% |
| 7 | FMR LLC | 2,315 | $4.2K | 0.1% | DOUBLED +428.5% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 71,037 | 131,987 | +85.8% | $237.6K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 42,831 | 79,002 | +84.5% | $142.2K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 20,119 | 46,352 | +130.4% | $83.4K | 2025-Q4 |
| FMR LLC | DOUBLED | 438 | 2,315 | +428.5% | $4.2K | 2025-Q4 |
| UBS Group AG | DOUBLED | 75,150 | 190,276 | +153.2% | $422.4K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 462,043 | 71,037 | -84.6% | $157.7K | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 71,537 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 1,188,953 | 1,615,003 | +35.8% | $2.4M | 2025-Q2 |
| VANGUARD GROUP INC | NEW | — | 484,798 | — | $717.5K | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 83,558 | 462,043 | +453.0% | $683.8K | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 175,070 | — | $259.1K | 2025-Q2 |
| UBS Group AG | DOUBLED | 2,087 | 75,150 | +3500.9% | $111.2K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEW | — | 36,034 | — | $53.3K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 6 | 21,892 | +364766.7% | $32.4K | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 86,354 | — | $221.1K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 191,987 | 85,618 | -55.4% | $219.2K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 170,216 | 83,558 | -50.9% | $213.9K | 2025-Q1 |
| UBS Group AG | NEAR_EXIT | 18,178 | 2,087 | -88.5% | $5.3K | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 43,058 | 170,216 | +295.3% | $320.0K | 2024-Q4 |
| UBS Group AG | DOUBLED | 292 | 18,178 | +6125.3% | $34.2K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 87,144 | 43,058 | -50.6% | $43.9K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (80% buy). Based on 5 analysts: 1 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$11.00 mean target
+455.6% upside
Strong Buy (1.00)
$10.00 Low
$12.00 High
| Metric | Value |
|---|---|
| Current Price | $1.98 |
| Target Low | $10.00 |
| Target Mean | $11.00 |
| Target Median | $11.00 |
| Target High | $12.00 |
| # Analysts | 2 |
| Recommendation | Strong Buy (1.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.01 | $-0.03 | $0.01 | 0.0% | -103.7% | 0↑ 1↓ | $0.0B | -17.4% | 2 |
| Next Q 2026-09-30 |
$-0.01 | $-0.03 | $0.01 | -133.3% | +0.0% | 1↑ 0↓ | $0.0B | -16.7% | 2 |
| Current FY 2026-12-31 |
$0.20 | $0.14 | $0.25 | 343.8% | -9.3% | 0↑ 2↓ | $0.1B | 48.5% | 2 |
| Next FY 2027-12-31 |
$0.05 | $-0.02 | $0.12 | -74.4% | -28.6% | 0↑ 2↓ | $0.1B | -13.7% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.010 | |
| 7d ago | $-0.030 | +0.020 |
| 30d ago | $0.270 | -0.280 |
| 60d ago | $0.270 | -0.280 |
| 90d ago | $0.050 | -0.060 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 19, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| May 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Apr 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Mar 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Feb 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Jan 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
1 mentions
0 bullish
0 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 17, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
IF YOU LIKE DRUGS LOOK AT THIS TICKER (PLYX)
▲ 1
💬 5
⚡ 0.0
May 13, 2026
earnings_calendar
PLX Q1 2026 Earnings Scheduled — 2026-05-13
May 8, 2026
earnings_calendar
PLX Q1 2026 Earnings Scheduled — 2026-05-08
Mar 30, 2026
short_volume
Short Volume: PLX — 62.2% short (0.3M / 0.5M)
Short: 327,807 | Exempt: 250 | TRF Vol: 527,303 | Short Ratio: 62.2% | Off-exchange volume (dark pool + OTC)
Mar 18, 2026
earnings_calendar
PLX Q4 2025 Earnings Before Market Open — 2026-03-18
Mar 12, 2026
earnings_calendar
PLX Q4 2025 Earnings Before Market Open — 2026-03-12